本文選題：肝癌診斷　切入點(diǎn)：GPC　出處：《中國地方病防治雜志》2017年07期 　論文類型：期刊論文

【摘要】：正目前主要應(yīng)用甲胎蛋白(AFP)作為肝癌血清標(biāo)志物。然而對于AFP的靈敏度報(bào)道不一,作為肝癌的診斷手段并不理想。據(jù)報(bào)道,磷脂酰肌醇聚糖3(GPC3)、熱休克蛋白70(HSP70)有望成為肝細(xì)胞癌的早期診斷標(biāo)志物[1]。為進(jìn)一步確認(rèn)GPC3和HSP70在乙肝相關(guān)肝癌診斷中的應(yīng)用價(jià)值,本研究對GPC3、HSP70以及聯(lián)合診斷的靈敏度和特異度進(jìn)行了系統(tǒng)研究。1資料與方法
[Abstract]:Currently AFP is mainly used as a serum marker for liver cancer. However, the sensitivity of AFP is not reported to be satisfactory, and the diagnosis of HCC is not ideal. Phosphatidylinositol 3 (GPC3), heat shock protein 70 (HSP70) is expected to be an early diagnostic marker for hepatocellular carcinoma [1]. To further confirm the value of GPC3 and HSP70 in the diagnosis of Hepatitis B related liver cancer. In this study, the sensitivity and specificity of GPC3 HSP70 and its combined diagnosis were systematically studied. 1 data and methods
【作者單位】： 唐山市傳染病醫(yī)院;
【分類號】：R512.62;R735.7
，

本文編號：1601085